. According to official website's inquiry, on June 9, 2020, the company, the manager of Dongying Forsyte Bioengineering Co., Ltd. and Chen Dong Holding Group Co., Ltd. signed the Chen Dong Group Biomedical Sector Restructuring Investment Agreement on June 5, agreeing to acquire the equity of Forsyte Company 100% for 290 million yuan. After the completion of the transaction, Foster Company became a wholly-owned subsidiary of Huaxi Bio. After meeting the merger conditions, it will be included in the merger scope of Huaxi biological statements as a business combination not under the same control.